Browsing by Author Borrego, Francisco
Showing results 1 to 6 of 6
Preview | Title | Author(s) | Issue Date |
---|---|---|---|
Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers. | Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Ruiz-Mateos, Ezequiel; Leal, Manuel; García-Obregón, Susana; Zenarruzabeitia, Olatz; Borrego, Francisco | 23-Jul-2018 | |
Editorial: NK Cell-Based Cancer Immunotherapy. | Borrego, Francisco; Larrucea, Susana; Solana, Rafael; Tarazona, Raquel | 27-Jun-2016 | |
Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. | Vitallé, Joana; Zenarruzabeitia, Olatz; Terrén, Iñigo; Plana, Montserrat; Guardo, Alberto C; Leal, Lorna; Peña, José; García, Felipe; Borrego, Francisco | 21-Jul-2017 | |
Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a | Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Leal, Manuel; Ruiz-Mateos, Ezequiel; Borrego, Francisco; Zenarruzabeitia, Olatz | 8-Apr-2020 | |
Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a. | Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Leal, Manuel; Ruiz-Mateos, Ezequiel; Borrego, Francisco; Zenarruzabeitia, Olatz | 8-Apr-2020 | |
Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease. | Naranjo, Javier; Borrego, Francisco; Rocha, José Luis; Salgueira, Mercedes; Martín-Gomez, Maria Adoración; Orellana, Cristhian; Morales, Ana; Vallejo, Fernando; Hidalgo, Pilar; Rodríguez, Francisca; Garófano, Remedios; González, Isabel; Esteban, Rafael; Espinosa, Mario | 29-Sep-2022 |